Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis

C K Chen1, S K Lin, P C Sham

  • 1Department of Psychiatry, Chang Gung Memorial Hospital, Taiwan.

Psychological Medicine
|December 16, 2003
PubMed
Abstract

Insights

Methamphetamine (MAMP) psychosis risk increases with earlier and heavier use. Pre-existing schizoid/schizotypal traits may predispose users to psychosis, with greater vulnerability leading to longer-lasting symptoms.

Area of Science:

  • Psychiatry
  • Neuroscience
  • Addiction Medicine

Background:

  • Long-term methamphetamine (MAMP) use can lead to psychosis, but individual susceptibility varies.
  • Factors influencing the development of MAMP-induced psychosis remain unclear.
  • This study investigates pre-morbid characteristics and psychiatric comorbidities in MAMP users with and without psychosis.

Purpose of the Study:

  • To characterize methamphetamine users.
  • To examine the relationship between pre-morbid personality, social function, and psychiatric disorders and the development of MAMP psychosis.
  • To identify risk factors for MAMP-induced psychosis.

Main Methods:

  • Recruited 445 amphetamine users from a psychiatric hospital and detention center in Taipei.
  • Assessed participants using the Diagnostic Interview for Genetic Studies (DIGS).
  • Interviewed parents using Premorbid Schizoid and Schizotypal Traits (PSST) and Premorbid Social Adjustment (PSA) schedules to compare pre-morbid characteristics and psychiatric comorbidities between MAMP users with and without psychosis.

Main Results:

  • MAMP users with psychosis exhibited symptoms mimicking schizophrenia, including auditory hallucinations (85%), persecutory delusions (71%), and delusions of reference (63%).
  • Compared to non-psychotic users, those with psychosis were younger at first MAMP use, used larger MAMP amounts, and had higher mean PSST scores.
  • MAMP users with psychosis also showed higher rates of major depressive disorder, alcohol dependence, and antisocial personality disorder.

Conclusions:

  • Earlier and heavier methamphetamine use is associated with an increased risk of psychosis.
  • Pre-morbid schizoid/schizotypal personality traits appear to predispose MAMP users to psychosis.
  • Greater personality vulnerability may correlate with longer psychosis persistence.

Related Concept Videos

Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...